Cost-benefit Evaluation of a Transdiagnostic Psychological Treatment for Emotional Disorders in Primary Care

NAActive, not recruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

May 31, 2025

Study Completion Date

April 30, 2026

Conditions
Emotional DisorderDepressionSomatoform DisordersAnxiety Disorders
Interventions
OTHER

Group brief transdiagnostic cognitive-behavioral therapy

An adaptation of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders (UP) (Barlow et al., 2015) and the IAPT programme (Clark, 2018). It has been developed by Cano-Vindel (González-Blanch et al., 2018) and consists in seven 90-minute sessions, provided by a non-assessor clinical psychologist in 12-16 weeks, with 8-10 participants per group. Sessions are weekly or biweekly, reducing their frequency as the intervention advances. The activities and homework proposed are supported with materials such as theory documents, a CD for progressive muscle relaxation, self-recording sheets, and a therapy web (www.desordenesemocionales.es).

OTHER

Individual brief transdiagnostic cognitive-behavioral therapy

An adaption of the group therapy, with the same phases. However, since it is an individual intervention, it is more flexible than group one and its contents and duration can be personalized. This intervention consists of a minimum of 6 and a maximum of 8 sessions of 30-60 minutes, provided by a clinical psychologist not involved in the assessments.

OTHER

Treatment as usual

Participants in this group will be provided the common primary care treatment by the GP, in a face-to-face consultation that seldom exceeds 10 minutes. TAU usually consists in pharmacological treatment prescribed by the GP, however, it might also consist in practical advice or even non-treatment (Watts et al., 2015). The first consultation will count as part of the recruitment process and, if the patient accepts to participate in the trial, no therapeutic help will be provided to them until they are allocated. Once in the TAU intervention, if the practitioner recommended any psychological treatment as part of it (e.g., referral to specialized care), the participant would be excluded to avoid contamination between clusters. TAU has not a specific amount of sessions; it will finish when the GP considers the patient is recovered.

Trial Locations (3)

14007

"Centro Sanitario Levante Sur Dr. Manuel Barragán Solís", Córdoba

14011

"Centro Sanitario Carlos Castilla del Pino", Córdoba

14550

Unidad de Salud Mental Comunitaria Montilla, Montilla

All Listed Sponsors
collaborator

State Research Agency, Spain

OTHER_GOV

lead

Universidad de Córdoba

OTHER